Chiesi España
Created in 1935
Social networks
1,900 16,259Activities
Technologies
Entity types
Location
Pl. d'Europa, 41, 43, 08908 L'Hospitalet de Llobregat, Barcelona, Spain
L'Hospitalet de Llobregat
Spain
Employees
Scale: 201-500
Estimated: 280
Engaged corporates
23
1 22Added in Motherbase
1 year, 9 months ago
healthtech Value proposition
[Automatic translation follows] As a B Corp company, we are driven by the #purpose of improving the quality of life of #people.
#WeAreChiesi
Chiesi is an international research-focused biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases and specialized care. Our mission is to improve people's quality of life and act responsibly for the benefit of the community and the environment.
By changing its legal status to a Charitable Corporation in Italy, the USA and France, Chiesi's commitment to creating shared value for society as a whole is legally binding and central to the company's decision-making. As a certified B Corp since 2019, we are part of a global community of companies that meet high standards of social and environmental impact. The company aims to achieve net zero greenhouse gas (GHG) emissions by 2035.
With over 85 years of experience, Chiesi is headquartered in Parma (Italy), operates in 31 countries and has more than 6,000 employees. The Group's R&D centre in Parma works alongside 6 other major R&D centres in France, the United States, Canada, China, the United Kingdom and Sweden.
To report adverse reactions or concerns about the safety of any of our medicines, contact the Chiesi Laboratories Pharmacovigilance Department at farmacovigilancia@chiesi.com or +34 934 948 000
CHIESI ESPAÑA, S.A.U. is the controller of your personal data, CHIESI will process your personal data for the purposes of managing the interactions between you and CHIESI through the information provided by you on social networks in which CHIESI has an active profile and for compliance with legal obligations related to the communication of adverse reactions.
For information on how we process your personal data and how to exercise your rights, you can refer to the Privacy Policy at this link: https://bit.ly/3oaChCm
Neonatology, Respiratory, Rare Diseases, Transplants, Consumer Healthcare, and CardiovascularOriginal language
Como compañía B Corp, nos impulsa el #propósito de mejorar la calidad de vida de las #personas.
#SomosChiesi
Chiesi es un grupo biofarmacéutico internacional centrado en la investigación que desarrolla y comercializa soluciones terapéuticas innovadoras en salud respiratoria, enfermedades raras y atención especializada. Nuestra misión es mejorar la calidad de vida de las personas y actuar de forma responsable para el beneficio de la comunidad y del medioambiente.
Al cambiar su estatus legal a Corporación Benéfica en Italia, EE.UU. y Francia, el compromiso de Chiesi de crear valor compartido para la sociedad en su conjunto es legalmente vinculante y central en la toma de decisiones de la compañía. Como B Corp certificada desde 2019, somos parte de una comunidad global de empresas que cumplen con altos estándares de impacto social y medioambiental. La compañía aspira a alcanzar las cero emisiones netas de gases de efecto invernadero (GEI) en 2035.
Con más de 85 años de experiencia, Chiesi tiene su sede en Parma (Italia), opera en 31 países y cuenta con más de 6.000 empleados. El centro de I+D del Grupo en Parma trabaja junto con otros 6 importantes centros de I+D en Francia, Estados Unidos, Canadá, China, Reino Unido y Suecia.
Para notificar reacciones adversas o dudas sobre la seguridad de alguno de nuestros medicamentos, contacta con el Dpto. de Farmacovigilancia de Laboratorios Chiesi en farmacovigilancia@chiesi.com o en el +34 934 948 000
CHIESI ESPAÑA, S.A.U. es la responsable del tratamiento de sus datos personales, CHIESI tratará sus datos personales a efectos de gestionar las interacciones entre Ud. y CHIESI a través de la información proporcionada por usted en RRSS en las que CHIESI cuenta con un perfil activo y para el cumplimiento de obligaciones legales relacionadas con la comunicación de reacciones adversas.
Para obtener información sobre cómo tratamos sus datos personales y cómo ejercer sus derechos, puede dirigirse a la Política de Privacidad en este link: https://bit.ly/3oaChCm
Neonatología, Respiratorio, Enfermedades Raras, Trasplantes, Consumer Healtcare, and Cardiovascular
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Other 16 Jul 2022 | | |
 AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 17 Nov 2021 | | |
 GSK Pharmaceutical, Pharmaceutical Manufacturing | GSK Pharmaceutical, Pharmaceutical Manufacturing | Other 5 Apr 2021 | | |
 Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 22 Apr 2020 | | |
 Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Other 22 Apr 2020 | | |
 Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 7 Oct 2020 | | |
 Fresenius Medical Care Pharmaceutical, Hospitals and Health Care | Fresenius Medical Care Pharmaceutical, Hospitals and Health Care | Other 18 May 2022 | | |
 Comunidad de Madrid National and local authorities, Government Administration | Comunidad de Madrid National and local authorities, Government Administration | Other 4 Jul 2022 | | |
 CaixaBank Bank, Banking | CaixaBank Bank, Banking | Other 20 Jul 2022 | | |
 Accenture Consulting, audit, Business Consulting and Services | Accenture Consulting, audit, Business Consulting and Services | Other 20 Jul 2022 | | |